Want to join the conversation?
SunTrust analyst Frank Atkins follows up by asking on allocation of capital in the M&A environment. CFO Andre Valentine says that $CVG has a strong free cash flow generation and it will look for things that would be accretive to the platform. $CVG is looking for client diversifications, diversifying revenue streams and geographic diversification.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?